InsidersTradesSigma
Browse the detailed record of transactions filed by Scheessele William John, Directeur Commercial. Director active across 1 companies, notably Humacyte, Inc.. Aggregated, 1 reports have been published. Total volume traded: €46k. The latest transaction was filed on 24 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
William John Scheessele is the Chief Commercial Officer at Humacyte, Inc. He is responsible for the company's commercial strategy, overseeing sales and marketing efforts.